Nature Communications

Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin

• Cheng-Hao Kuo
• Glen P. Carter
• Benjamin P. Howden
• Tsai-Wei Huang
• Zhujun Cao
• Yee Hui Yeo
• Chun-Ying Wu

2025-12-11

Full text

DOI https://doi.org/10.1038/s41467-025-67326-y